Type 2 Diabetes

People who take a common drug for type 2 diabetes may be at risk for serious drug interactions if they add the blood thinner warfarin to the mix.

Not only do women with type 2 diabetes have double the risk of cardiovascular disease compared with men, but they also need more frequent and intense physical activity to lower that risk.

Diabetic ulcers and necrosis on the foot may be associated with cognitive decline.

Physicians don't have enough time to properly research each medication on their own. The pharmaceutical industry needs to better teach physicians about their medications instead of driving patients to demand them.

A powerful new drug discovery technique may have uncovered a candidate compound for treating type 2 diabetes.

Researchers in China retrospectively studied health records of 430,000 people age 50 years or older who had recently been diagnosed with diabetes to investigate the link between dementia risk and the severity and progression of diabetes.

A recent study looked at two GLP-1 agonists to compare 6 attributes of T2DM treatment and determine the importance patients placed on each one.

Is coffee good for you and your patients? What if it’s decaffeinated or loaded with sugar or cream? A new study adds fuel to the on-going debate.

Getting to the bottom of why an SGLT2 inhibitor produced a reduction in cardiovascular events is part of the challenge and excitement of medicine.

Study results suggest that C-reactive protein levels might be used as a biomarker to determine the severity of diabetic retinopathy. To this point, such a connection has remained controversial.

A new tool that calculates risks of certain diabetes complications could help your patients make more informed decisions about their treatment.

What if exercise could prevent dementia? A growing body of observational (but not interventional) research suggests that physical activity seems to be associated with vigorous cognitive aging.

Nonalcoholic fatty liver disease (NAFLD) is now the most common hepatic pathology in developed nations. Public health officials are worried, as NAFLD increases the likelihood of diabetes, cardiovascular disease and chronic kidney disease.

Researchers say that patients using YouTube videos to obtain advice about their peripheral nerve pain are being misguided about half of the time.

There are pros and cons to giving patients once-weekly injections of glucagon-like peptide-1 receptor agonists (GLP-1RAs), a new group of drugs to treat type 2 diabetes.

When a medical condition is paired with another, it could make for a trickier situation. New research found that some diseases can significantly impact platelet function while others appear to have no effect.

The verdict is in regarding SGLT2 inhibitor use and diabetic ketoacidosis. Expert panel conclusions are summarized.

Three SGLT2 inhibitors have similar drug costs per unit dose, but what are the drug costs based on treatment response?

A recent study suggests that high salt intake is closely associated with elevated risks of developing non-alcoholic fatty liver disease (NAFLD).

Increasing daily intake of walnuts has been linked to lower cholesterol levels, overall weight, and quality of diet.

Managing diabetes is especially tricky this time of year. Maintaining glucose targets during the holidays is about more than diet control.

Does high-intensity exercise lead to high cardiometabolic rewards in a type 2 diabetes population?

What happens when T2DM patients on daily insulin add a GLP-1 receptor agonist to their treatment?

A heartrending sense of limits and financial hardships is tempered by the crackling energy of the volunteers and celebrations of patient successes.

As more is learned about the affect of newly developed PCSK9 medications cardiologists are looking at new patient populations and how to provide them the highest quality care.

Adding the GLP-1 receptor agonist to insulin therapy resulted in decreased body weight and insulin requirements, but how did the drug affect HbA1c?

In non-diabetic patients, researchers have shown sirolimus-eluting stents to be more effective than paclitaxel-eluting stents, leading to better clinical outcomes. Some researchers believe that T2DM attenuates the mammalian target of rapamycin (mTOR) signaling pathway. This could influence the choice of stents, and has created a controversy.

Severe hypoglycemia is a complication of insulin use that occurs in 20% of insulin-treated patients on a monthly basis. A small number of these patients become unconscious or seize as a result of severe hypoglycemia. Hospitals are prepared to intervene, but often in the community, a Good Samaritan needs to reconstitute and injection dry powder formulations of subcutaneous and intramuscular glucagon for unconscious or seizing patients.

Researchers see promise in vitamin E treatment for NASH.

Despite the many glucose monitoring and insulin delivery devices that are available, many diabetics who use them remain uncontrolled and experience hypoglycemia. Researchers dream of the day that drug-device combinations will track diabetics' glucose levels and deliver appropriate insulin dose.